Wockhardt receives DCGI approval for new drug to tackle AMR

Pharma/BioPharma |  News | 0 Comment | 16 Jan, 2020

Indian drug regulator, DCGI has approved Wockhardt’s 2 new antibiotics, EMROK (IV) and EMROK O (Oral), for acute bacterial skin and skin structure Infections including diabetic foot i...Read more

FDA approves Merck’s keytruda for Invasive bladder cancer treatment

Pharma/BioPharma |  News | 0 Comment | 09 Jan, 2020

Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monothera...Read more

Serum Institute, Aragen Bio announce vaccine development collaboration

Pharma/BioPharma |  News | 0 Comment | 09 Jan, 2020

Aragen Bioscience, Inc., a subsidiary of GVK BIO and one of the leading preclinical ORCs specializing in the development of monoclonal antibodies and other products based on large molecules...Read more

IIL unveils eco-friendly pack for anti-rabies vaccine

Pharma/BioPharma |  News | 0 Comment | 08 Jan, 2020

As a socially committed organization Human Biologicals Institute, a division of Indian Immunologicals Limited (IIL) - a leading vaccines company, has announced that it has ta...Read more

AstraZeneca’s heart failure drug Farxiga gets FDA priority review

Pharma/BioPharma |  News | 0 Comment | 07 Jan, 2020

AstraZeneca has announced the US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) and granted Priority Review for Farxiga (dapagliflozin)...Read more

Glenmark receives ANDA approval for Deferasirox Tablets

Pharma/BioPharma |  News | 0 Comment | 07 Jan, 2020

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Deferasirox Tablets for Oral  Suspension,  125  mg...Read more

Indoco Remedies receives FDA nod for gout medication

Pharma/BioPharma |  News | 0 Comment | 02 Jan, 2020

Indoco Remedies Ltd., headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries. The company has received final approval of its ANDA for...Read more

Novadoz /MSN Labs get FDA approval of generic Febuxostat tablets

Pharma/BioPharma |  News | 0 Comment | 01 Jan, 2020

Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs, based in Hyderabad India, has received FDA approval for their generic version of Febuxostat 40mg an...Read more

Dr Reddy's launches generic hypotensive injection in US

Pharma/BioPharma |  News | 0 Comment | 31 Dec, 2019

Dr. Reddy’s Laboratories Ltd. has announced the launch of Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial, the therapeutic generic equivalent of Nitropress...Read more

Nectar Biopharma rolls out generic diabetes drug

Pharma/BioPharma |  News | 1 Comment | 26 Dec, 2019

In what comes as good news for over 72 million diabetics in India, more affordable diabetic care is finally here with Nectar Biopharma, a leading company specialising in generic formulation...Read more

Mankind, Glenmark to co-market anti-diabetes drug in India

Pharma/BioPharma |  News | 0 Comment | 24 Dec, 2019

Mankind Pharmaceuticals Ltd. and Glenmark Pharmaceuticals Ltd. have inked a sub-licensing agreement to co-market sodium glucose co-transporter-2 (SGLT2) inhibitor, Remogliflozin Etabon...Read more

Panacea Biotec receives $24.32M award from UN Agencies

Pharma/BioPharma |  News | 0 Comment | 23 Dec, 2019

New Delhi based biotechnology company Panacea Biotec has received Awards worth USD 24.32 Million (Over Rs.170 crores) from U.N. Agencies (UNICEF and PAHO) for supply of its Easyfi...Read more

Lupin’s Alliance Partner Concord receives approval for Mycophenolic Acid Delayed Release Tablets

Pharma/BioPharma |  News | 0 Comment | 20 Dec, 2019

Lupin in alliance with Concord Biotech Limited (Concord) announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for Mycophenolic Acid Delayed...Read more

Lupin launches Doxercalciferol Injection

Pharma/BioPharma |  News | 0 Comment | 19 Dec, 2019

Lupin announced the launch of Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) Multi-dose Vials, having received an approval from the United States Food and Drug Administration (U.S. FDA) e...Read more

Hetero launches 3-in-1 single pill for HIV treatment

Pharma/BioPharma |  News | 0 Comment | 19 Dec, 2019

Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of antiretroviral drugs,  announced the launch of the latest 3-in-1 antiret...Read more

Cipla acquires trademark rights of Vysov

Pharma/BioPharma |  News | 0 Comment | 17 Dec, 2019

Cipla has acquired the brand name and trademark rights for Vysov ® & Vysov M® (Vildagliptin + Metformin) of the anti-diabetic drug, Vildagliptin for the Indian market. The comp...Read more

Panacea Biotec launches anti-diabetes drug ViLACT

Pharma/BioPharma |  News | 0 Comment | 11 Dec, 2019

Panacea Biotec is pleased to announce launch of brand ViLACT in India. ViLACT is used in the treatment of Uncontrolled Type 2 Diabetes Mellitus patients with HbA1c >6.5%.   VilACT...Read more

FDA approves Amgen's biosimilar AVSOLA

Pharma/BioPharma |  News | 0 Comment | 09 Dec, 2019

Amgen has announced that the U.S. Food and Drug Administration (FDA) has approved AVSOLA™ (infliximab-axxq) for all approved indications of the reference product, Remic...Read more